Viteva  Home logo
Supplement Safety

 Untitled 1
Quercetin Research

Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation.

Molecular imaging of the biological effects of quercetin and quercetin-rich foods.

Safety of quercetin for clinical application (Review).

Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA.

Quercetin reduces illness but not immune perturbations after intensive exercise.

Quercetin reduces blood pressure in hypertensive subjects.

Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation.

Quercetin: potentials in the prevention and therapy of disease.

Oral quercetin supplementation and blood oxidative capacity in response to ultramarathon competition.

Antihypertensive effects of the flavonoid quercetin.

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.

Quercetin does not affect rating of perceived exertion in athletes during the Western States endurance run.

The multiple faces of quercetin in neuroprotection.

Effects of the dietary flavonoid quercetin upon performance and health.

Dietary quercetin supplementation is not ergogenic in untrained men.
 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva